BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16386891)

  • 1. The two human homologues of yeast UFD2 ubiquitination factor, UBE4A and UBE4B, are located in common neuroblastoma deletion regions and are subject to mutations in tumours.
    Carén H; Holmstrand A; Sjöberg RM; Martinsson T
    Eur J Cancer; 2006 Feb; 42(3):381-7. PubMed ID: 16386891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.
    Krona C; Ejeskär K; Abel F; Kogner P; Bjelke J; Björk E; Sjöberg RM; Martinsson T
    Oncogene; 2003 Apr; 22(15):2343-51. PubMed ID: 12700669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of the gene encoding for the U-box-type ubiquitin ligase UBE4A in human tissues.
    Contino G; Amati F; Pucci S; Pontieri E; Pichiorri F; Novelli A; Botta A; Mango R; Nardone AM; Sangiuolo FC; Citro G; Spagnoli LG; Novelli G
    Gene; 2004 Mar; 328():69-74. PubMed ID: 15019985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.
    Zage PE; Sirisaengtaksin N; Liu Y; Gireud M; Brown BS; Palla S; Richards KN; Hughes DP; Bean AJ
    Cancer; 2013 Feb; 119(4):915-23. PubMed ID: 22990745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines.
    Mathysen D; Van Roy N; Van Hul W; Laureys G; Ambros P; Speleman F; Wuyts W
    Eur J Cancer; 2004 May; 40(8):1255-61. PubMed ID: 15110891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.
    Boensch M; Oberthuer A; Fischer M; Skowron M; Oestreich J; Berthold F; Spitz R
    Diagn Mol Pathol; 2005 Sep; 14(3):177-82. PubMed ID: 16106200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.
    Krona C; Ejeskär K; Carén H; Abel F; Sjöberg RM; Martinsson T
    Br J Cancer; 2004 Sep; 91(6):1119-30. PubMed ID: 15328517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low UBE4B expression increases sensitivity of chemoresistant neuroblastoma cells to EGFR and STAT5 inhibition.
    Memarzadeh K; Savage DJ; Bean AJ
    Cancer Biol Ther; 2019; 20(12):1416-1429. PubMed ID: 31475882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours.
    Carén H; Fransson S; Ejeskär K; Kogner P; Martinsson T
    Br J Cancer; 2007 Nov; 97(10):1416-24. PubMed ID: 17940511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.
    Martinsson T; Sjöberg RM; Hallstensson K; Nordling M; Hedborg F; Kogner P
    Eur J Cancer; 1997 Oct; 33(12):1997-2001. PubMed ID: 9516841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
    Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
    Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
    Plantaz D; Vandesompele J; Van Roy N; Lastowska M; Bown N; Combaret V; Favrot MC; Delattre O; Michon J; Bénard J; Hartmann O; Nicholson JC; Ross FM; Brinkschmidt C; Laureys G; Caron H; Matthay KK; Feuerstein BG; Speleman F
    Int J Cancer; 2001 Mar; 91(5):680-6. PubMed ID: 11267980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
    Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Shishikura T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Tomioka N; Sakiyama S; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Nakagawara A
    Oncogene; 2000 Aug; 19(37):4302-7. PubMed ID: 10980605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations involving chromosome 1p in children with neuroblastoma.
    Avigad S; Tamir Y; Yaniv I; Goshen J; Kaplinsky C; Cohen IJ; Zaizov R
    Isr J Med Sci; 1994 Aug; 30(8):639-41. PubMed ID: 7913920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas.
    Huang S; Lichtenauer UD; Pack S; Wang C; Kim AC; Lutchman M; Koch CA; Torres-Cruz J; Huang SC; Benz EJ; Christiansen H; Dockhorn-Dworniczak B; Poremba C; Vortmeyer AO; Chishti AH; Zhuang Z
    Eur J Clin Invest; 2001 Oct; 31(10):907-14. PubMed ID: 11737230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.
    Abel F; Sjöberg RM; Ejeskär K; Krona C; Martinsson T
    Br J Cancer; 2002 Feb; 86(4):596-604. PubMed ID: 11870543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelotype of neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.